PMDH3- THE USE OF SURROGATE ENDPOINT DATA IN EVALUATING TREATMENT EFFICACY- IMPACT ON DECISION-MAKING AND EXPENDITURE WITHIN THE AUSTRALIAN PHARMACEUTICAL BENEFITS SCHEME
Sep 1, 2000, 00:00
10.1016/S1098-3015(11)70803-8
https://www.valueinhealthjournal.com/article/S1098-3015(11)70803-8/fulltext
Title :
PMDH3- THE USE OF SURROGATE ENDPOINT DATA IN EVALUATING TREATMENT EFFICACY- IMPACT ON DECISION-MAKING AND EXPENDITURE WITHIN THE AUSTRALIAN PHARMACEUTICAL BENEFITS SCHEME
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)70803-8&doi=10.1016/S1098-3015(11)70803-8
First page :
Section Title :
Open access? :
No
Section Order :
186